InvestorsHub Logo
Followers 4
Posts 227
Boards Moderated 0
Alias Born 05/03/2018

Re: None

Tuesday, 09/10/2019 2:46:16 AM

Tuesday, September 10, 2019 2:46:16 AM

Post# of 424447
https://www.practiceupdate.com/journalscan/60455/2/2?elsca1=emc_enews_daily-digest&elsca2=email&elsca3=practiceupdate_cardio&elsca4=cardiology&elsca5=newsletter&rid=NDE0ODg4MzcyNjMyS0&lid=10332481

Bhatt man is right, AHA guidance is an insult to AMRN which differed totally to ESC ... "but it did seem a bit premature to recommend that product prior to the completion of the trial because outcome data currently only support use of icosapent ethyl."

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News